Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.65 - $1.31 $1,235 - $2,489
-1,900 Reduced 67.86%
900 $0
Q1 2023

May 15, 2023

SELL
$0.38 - $1.07 $4,598 - $12,947
-12,100 Reduced 81.21%
2,800 $2,000
Q4 2022

Feb 14, 2023

SELL
$0.32 - $0.52 $15,584 - $25,324
-48,700 Reduced 76.57%
14,900 $5,000
Q3 2022

Nov 14, 2022

BUY
$0.43 - $1.56 $27,348 - $99,216
63,600 New
63,600 $27,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.